smallcase-logo
smallcase-logo

Pharma Select

Invest in India's booming pharma sector, where cost efficiency meets global export dominance.


Suitable For

Moderate Investors

PE Ratio

25.61

Min. Investment

₹14,947

Recommended Investment

Upto 25 Lacs

3M CAGR

10.60%


Performance

Current value of ₹ 100 invested at inception would be:

₹ 110.6

₹ 101.44

Note: All performance graphs & numbers are calculated using only the live data and includes rebalances. Past performance doesn't include cost or guarantee future returns.

About this smallcase

Why should you invest in this smallcase?

The Indian pharma industry has grown at a CAGR of 8% over the past five years, now valued at $50 billion. It's projected to reach $130 billion by 2030 with a CAGR of 10.7%. India supplies 20% of global pharma volumes and 70% of vaccines, with FDA approval success rate of over 93% for Indian drugs. 


This growth and India's potential to lead globally are key reasons for curating this portfolio.


Right To Win


  • Pharma is a $1.4 trillion industry globally & India’s share in this is expected to increase with the competitive advantage of Indian drugs strengthening its global position and boosting exports
  • India already exports over 50% of its domestic output and is the medical tourism capital of the globe.
  • Manufacturing costs in India are 30% lower than in the US, & R&D more cost-efficient than in 90% of developed markets.
  • Lower production cost + competitive advantage + growing scope = Indian pharma being the next big thing. 


About Our Portfolio 


  • This portfolio taps into India’s booming pharma sector, featuring 10-12 top companies. We’ve identified key opportunities in export-oriented companies with many approved APIs and active R&D. 
  • This portfolio benefits from the super-high FDIs in pharma & Government incentives, like increased funding for bulk drug parks and 100% Greenfield investment, further bolstering the sector.


Pharma Select by Green Portfolio is a limited portfolio ideal for investors looking to take concentrated positions in high-growth sectors like pharmaceuticals.


Show Less
Show More

Subscribe to see the constituents of this portfolio.

Subscribe Now

Subscription Plans

Subscribing to this smallcase will give you access to the stocks in the model portfolio of this strategy, as well as access to timely rebalance updates and stock alerts. If you still have questions, feel free to reach out to us.

Why This Pricing?
₹3,540₹2,360

3 Months

₹ 787 / mo

Subscribe Now
₹5,900₹4,720

6 Months

₹ 787 / mo

Subscribe Now
₹9,440₹7,080

12 Months

₹ 590 / mo

Subscribe Now

FAQs

A smallcase is a curated basket of stocks/ETFs* that reflects a certain objective (ideas, themes, strategies), backed by the research of Green Portfolio. You can invest in a smallcase in 2 clicks.

*ETFs (Exchange Traded Funds) are baskets of securities that track an underlying index (Nifty, Gold, etc) and can be bought and sold on the exchange.

By subscribing to a smallcase, you get access to the stocks and weights that are within the portfolio, since we are integrated with 16 of the major brokers in the country, the process of investing in the portfolio, rebalancing in a timely manner, as well as topping up becomes super easy and a one click process. Subscription is a fixed cost regardless of the amount that you choose to invest in the smallcase.

Taxes for smallcases of stocks follow the same guidelines as for individual equities. Short-term capital gains tax of 15% applies to stocks sold within 12 months, excluding losses. Long-term capital gains tax of 10% applies to stocks sold after 12 months with gains exceeding Rs. 1,00,000, effective from April 1, 2018. For more information, please refer to the FAQs provided by the Central Board of Direct Taxes - http://incometaxindia.gov.in/News/FAQ-on-LTCG.pdf.

Dividends are taxed in the hands of recipients at their applicable rates.

Green Portfolio smallcases are currently available on several brokers including Alice blue, Angel One, AxisDirect, Nuvama, Groww, HDFC Securities, IIFL Securities, Kotak Securities, Motilal Oswal, Trustline, Upstox, Zerodha, 5 paisa, ICICI direct, Dhan, Fundzbazar, and Fisdom. To explore and invest in smallcases, you can log in to your existing account with any of these brokers or open a Demat & trading account with them.

You can schedule a one-on-one meeting with our team and clear all your doubts by scheduling a call here.

You can find the refund policy here.
Investment Performance

Principal Amount

Duration

Gold

Bank FD

Equity Smallcap

Pharma Select

Pharma Select

Subscribe at ₹590 per month

More Smallcases

The best of defense, railway, and green energy companies in the portfolio that grows with India.

Min. Investment

₹53,157

3M CAGR

2.20%

Suitable For

Aggressive Investors

Capturing India’s automotive boom through rising stars and key suppliers.

Min. Investment

₹17,363

3M CAGR

4.52%

Suitable For

Moderate Investors

Invest in smallcap stocks which can generate multifold returns.

Min. Investment

₹59,138

3Y CAGR

34.92%

Suitable For

Aggressive Investors

Blogs

Wednesday, Mar 8, 2023

THE IMPORTANCE OF TAX-EFFICIENT PORTFOLIO MANAGEMENT
Read More

Wednesday, Apr 5, 2023

How Smallcase is changing the game for Retail Investors
Read More

Saturday, Dec 2, 2023

Essential Factors to Consider Before Hiring a PMS Manager
Read More